ARCHIVE: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
:[[Media:QIBA FDG-PET Profile v104 06Nov2013.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v1.04) Reviewed Draft (Public Comments Addressed)]] ''06NOV2013'' | |||
:[[Media:QIBA_FDG-PET_Profile_v104_pre02Aug.call.pdf|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v1.04) Version for Public Comment]] ''01AUG2013'' | |||
:[[Media:QIBA_Public_Comment_1 04_pre02Aug.call -OPEN.nonDCOMitems.pdf|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v1.04) Summary of Open Public Comment Items for Resolution]] ''01AUG2013'' | |||
:[[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wTC-Roster.pdf|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v1.03) Version for Public Comment]] ''09MAR2013'' | |||
:[[Media:QIBA FDG-PET Profile v102 rforPublicComment 21Feb2013.pdf|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v1.02) Version for Public Comment]] ''21FEB2013'' | |||
:[[Media:QIBA Public Comment FEEDBACK FDG-PET WholeBody v1 03 09Mar2013.pdf|QIBA Profile: FDG-PET Whole Body v1.03 - Public Comment Summary - Updated 09MAR2013]] | |||
*[[Media:QIBA FDG-PET Profile v0.9.5 ep 25OCT2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.9.5)]] ''4NOV2012'' | |||
*[[Media:QIBA FDG-PET Profile v0.9.5 25OCT2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.9.5)]] ''25OCT2012'' | |||
*[[Media:QIBA FDG-PET Profile v0.7.3 ep 09JUN2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3)]] ''09JUN2012'' | *[[Media:QIBA FDG-PET Profile v0.7.3 ep 09JUN2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3)]] ''09JUN2012'' | ||
*[[Media:QIBA FDG-PET Profile v0.7.3 31MAY2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3)]] ''31MAY2012'' | *[[Media:QIBA FDG-PET Profile v0.7.3 31MAY2012.doc|QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3)]] ''31MAY2012'' | ||
Latest revision as of 20:45, 10 November 2016
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.9.5) 4NOV2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.9.5) 25OCT2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3) 09JUN2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3) 31MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7) 23MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.6.1.8) 11MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.5.9) 08Mar2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.8) 03Feb2012
- FDG-PET/CT Profile: Status Update and Plan Presentation from 02.03.2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.7) 01-16-2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.6) 01-08-2012
- Whole Body FDG-PET Word version of Profile applicable to multiple indications, 04-19-2011
- Whole Body FDG-PET Word version of Profile applicable to multiple indications, 03-12-2011
- Profile: FDG-PET Whole Body First version of Profile, 2009 (currently inactive)